CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-08 | Koppikar Utpal Director | Purchase | +5,667 | $5.60 | $32K | 5,667 |
| 2022-04-12 | Hirsch Andrew President & CEO | Purchase | +10,000 | $8.40 | $84K | 10,000 |
| 2020-10-06 | MCKEE WILLIAM Chief Financial Officer | Purchase | +5,263 | $19.00 | $100K | 5,263 |
| 2020-10-06 | COHEN MARC A Director | Purchase | +5,030 | $19.00 | $96K | 5,030 |
| 2020-10-06 | Salter Malcolm Director | Purchase | +1,315 | $19.00 | $25K | 15,994 |
Page 1 of 1 · 5 trades